Tumor necrosis factor receptor 2
US6673908B1 · kind B1 · utility
111Cited by
2References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 1, 2001 |
| Grant date | Jan 6, 2004 |
| Priority date | — |
| Expiry date | Nov 12, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/7151
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure describes the use of genetic variance information for genes involved in inflammatory or immunologic disease, disorder, or dysfunction. The variance information is indicative of the expected response of a patient to a method of treatment. Methods of determining relevant variance information and additional methods of using such variance information are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.